Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Sales | 2,613 | 3,647 | 2,492 | 370 | 327 |
| Gross Profit | 2,613 | 3,647 | 2,492 | 370 | 327 |
| Operating Expenses | 6,423 | 7,243 | 5,482 | 3,930 | 3,788 |
| Operating Income | -3,811 | -3,596 | -2,990 | -3,560 | -3,462 |
| Other Income | -3,565 | 635 | -7,666 | 96 | -114 |
| Pre-tax Income | -7,376 | -2,962 | -10,657 | -3,465 | -3,576 |
| Net Income Continuous | -7,376 | -2,962 | -10,657 | -3,465 | -3,576 |
| Minority Interests | -30 | -14 | -4 | N/A | N/A |
| Net Income | $-7,346 | $-2,948 | $-10,653 | $-3,465 | $-3,576 |
| EPS Basic Total Ops | -1.44 | -1.44 | -9.12 | -3.84 | -4.32 |
| EPS Basic Continuous Ops | -1.50 | -1.51 | -8.93 | -3.78 | -3.90 |
| EPS Diluted Total Ops | -1.44 | -1.44 | -9.12 | -3.84 | -4.32 |
| EPS Diluted Continuous Ops | -1.50 | -1.51 | -8.93 | -3.78 | -3.90 |
| EBITDA(a) | $-3,207 | $-3,060 | $-2,666 | $-3,349 | $-3,178 |